Table 3 Safety endpoint and procedural adverse events
Eventa | Tailored (n = 187) | Anatomical (n = 183) | P valueb |
---|---|---|---|
Subjects with major procedure-related complications | 5 | 5c | >0.99 |
Cardiac tamponade or perforation | 2 | 2 | >0.99 |
Bradycardia with pacemaker implantation | 1 | 1 | >0.99 |
Severe cardiac decompensation | 1 | 1 | >0.99 |
Puncture-site hemorrhage requiring transfusion | 0 | 1 | >0.99 |
Transient phrenic nerve palsy | 1 | 0 | >0.99 |
Pneumonia aspiration | 0 | 1 | >0.99 |
Subjects with minor procedure-related complications | 15d | 6d | 0.07 |
Fluid overloade | 9 | 3 | 0.14 |
Pericarditis or pericardial effusionf | 4 | 0 | 0.12 |
Vascular access complication | 3 | 3 | >0.99 |
Post-ablation fever | 1 | 0 | >0.99 |
Abnormal ECG requiring hospitalization | 0 | 1 | >0.99 |
Subjects with non-procedure-related adverse events | 3 | 0 | 0.25 |
Deathg | 2 | 0 | 0.50 |
Transient ischemic attack | 1 | 0 | >0.99 |